Effect of probiotic and metformin combination therapy on insulin resistance in polycystic ovary syndrome compared with metformin alone
Abstract
Background: Insulin resistance in PCOS can be aggravated by gut microbiota dysbiosis. Probiotics may improve microbial balance and insulin sensitivity and, in combination with metformin, improve glycemic control while reducing side effects. This study aimed to compare the effects of probiotic–metformin combination therapy versus metformin alone on insulin resistance in PCOS patients.
Methods: This randomized controlled trial at BSMMU included 60 infertile women with PCOS and insulin resistance. Participants were randomized into two groups: one received probiotics (Lactobacillus and Bifidobacterium, 4 billion CFU twice daily for 12 weeks) plus metformin and the control group received metformin alone. Fasting blood sugar and insulin were measured pre- and post-treatment to assess insulin resistance.
Results: In the experimental group (probiotics+metformin), FBS, fasting insulin and HOMA-IR decreased significantly after 12 weeks (5.1±0.6 vs 5.5±0.9 mmol/l; 10.2±3.8 vs 17.5±5.5 µIU/ml; 2.3±0.9 vs 4.3±1.5). Similar significant reductions were observed in the control group (metformin alone) for FBS (5.3±0.6 vs 5.4±0.5 mmol/l), fasting insulin (10.8±4.3 vs 17.6±7.4 µIU/ml) and HOMA-IR (2.6±1.4 vs 4.2±1.6). However, the mean changes between groups were not statistically significant.
Conclusions: Probiotic–metformin therapy improved insulin resistance, but not significantly more than metformin alone and had fewer, non-significant side effects.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 60 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.